ANC-501 in the Treatment of Adults With Major Depressive Disorder
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05439603 |
|
Recruitment Status :
Recruiting
First Posted : June 30, 2022
Last Update Posted : December 8, 2022
|
Sponsor:
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.
Information provided by (Responsible Party):
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 25, 2023 |
| Estimated Study Completion Date : | March 25, 2023 |